News Focus
News Focus
icon url

DewDiligence

10/03/23 10:55 AM

#249140 RE: DewDiligence #237445

LLY acquires PNT for $12.50/sh cash—an 87% premium to yesterday’s close:

https://www.prnewswire.com/news-releases/lilly-to-acquire-point-biopharma-to-expand-oncology-capabilities-into-next-generation-radioligand-therapies-301945243.html

The nominal deal value is $1.4B; however, PNT has ~$800M in net cash and is due to receive at least $250M in milestone payments from LNTH, so LLY is not paying much for PNT’s radioligand pipeline.